Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment

ddPCR of cell free DNA enables real time monitoring of patients on 3rd generation TKIs. As resistance mechanisms are variable, monitoring levels of the initial activating EGFR mutation may facilitate more reliable detection of progression.